{"nct_id":"NCT02094261","title":"Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2014-05-20","start_date_type":"ACTUAL","primary_completion_date":"2015-05-01","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}